Stifling this effort are conflicting data regarding concordance between PD‐1 and PD‐L1 expressions in primary and metastatic tumors from the same patient, and lack of data on whether expression of these markers in metastatic ccRCC is associated with cancer‐specific survival. The gene discussed is CD274; the disease is cancer.